Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.315 USD | -1.63% | +16.49% | +43.10% |
03-20 | North American Morning Briefing : Markets on Hold -2- | DJ |
03-19 | JPMorgan Upgrades Mersana Therapeutics to Neutral From Underweight, Price Target is $5 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.10% | 412M | |
-1.34% | 104B | |
+3.98% | 97.47B | |
+5.59% | 22.25B | |
-13.44% | 21.68B | |
-9.51% | 18.2B | |
-39.98% | 17.02B | |
-11.54% | 16.36B | |
+8.41% | 14.39B | |
+41.72% | 12.37B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Sector Update: Health Care Stocks Ending Near Tuesday Session Highs